Lifeboat Foundation

Over the past few years, the business world has increasingly turned towards intelligent solutions to help cope with the changing digital landscape. Artificial intelligence (AI) enables devices and things to perceive, reason and act intuitively—mimicking the human brain, without being hindered by human subjectivity, ego and routine interruptions. The technology has the potential to greatly expand our capabilities, bringing added speed, efficiency and precision for tasks both complex and mundane.

To get a picture of the momentum behind AI, the global artificial intelligence market was valued at $62.35 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 40.2% from 2021 to 2028. Given this projection, it’s not surprising that tech giants such as AWS, IBM, Google and Qualcomm have all made significant investments into AI research, development, disparate impact testing and auditing.

My coverage area of expertise, fintech (financial technology), is no exception to this trend. The AI market for fintech alone is valued at an estimated $8 Billion and is projected to reach upwards of $27 Billion in the next five years. AI and machine learning (ML) have penetrated almost every facet of the space, from customer-facing functions to back-end processes. Let’s take a closer look at these changing dynamics.

The COVID-19 crisis led to fundamental changes in how we conduct business. The big question today is whether these innovations will be sustained and built upon after the crisis.

Don’t let the titanium metal walls or the sapphire windows fool you. It’s what’s on the inside of this small, curious device that could someday kick off a new era of navigation.

For over a year, the avocado-sized vacuum chamber has contained a cloud of atoms at the right conditions for precise navigational measurements. It is the first device that is small, energy-efficient and reliable enough to potentially move quantum sensors—sensors that use quantum mechanics to outperform conventional technologies—from the lab into commercial use, said Sandia National Laboratories scientist Peter Schwindt.

Sandia developed the chamber as a core technology for future navigation systems that don’t rely on GPS satellites, he said. It was described earlier this year in the journal AVS Quantum Science.

You might know that the size of the pupils in our eyes changes depending on how well lit our environment is, but there’s more to the story: Scientists have now discovered that the pupil also shifts in size depending on how many objects we’re observing.

The more objects in a scene, the bigger the pupil grows, as if to better accommodate everything that it has to look at. This “perceived numerosity” is a simple and automatic reflex, the new research shows.

In a new study, researchers observed the pupil sizes of 16 participants while they looked at pictures of dots. In some of the pictures, the dots were linked together in dumbbell shapes – creating the illusion that there were fewer objects – and pupil size then shrank.

Circa 2012

https://www.youtube.com/watch?v=3VDsguNyJ0c&feature=share

Growing veggies on a thin film that allows nutrients and water to pass through while blocking viruses and bacteria.

[Skip Intro] 0:46
Watch more full episodes of Japan’s Top Inventions on NHK WORLD-JAPAN!
https://www3.nhk.or.jp/nhkworld/en/ondemand/program/video/to…-jti034-hp.
More quality content available on NHK WORLD-JAPAN!
https://www3.nhk.or.jp/nhkworld/en/ondemand/video/?cid=wohk-yt-2108-jti034-hp.

Continue reading “Film Farming — Japan’s Top Inventions” »

Circa 2020 o.o Basically a molecular printer could make your own vaccine for any disease.

Tesla Inc is building mobile molecule printers to help make the potential COVID-19 vaccine being developed by CureVac in Germany, the electric-car maker’s Chief Executive Officer, Elon Musk, tweeted on Wednesday.

Georgia Tech scientists believe that microbes could be the key to producing the rocket fuel needed to take humans from Mars back to Earth.

Dr. Ann Marie Kimball (https://epi.washington.edu/faculty/kimball-ann-marie/) is a physician, epidemiologist and currently holds the roles of Associate Fellow at the international affairs think tank Chatham House, and Vice Chair, COVID 19 task force, at The Rotary Foundation / Rotary International.

Previously, Dr. Kimball served as a strategic advisor to the Rockefeller Foundation, supporting the strengthening and development of strategies for Ebola, post-Ebola, and health crisis response, including planning and guiding the formation of a regional disease surveillance network in collaboration with Connecting Organizations for Regional Disease Surveillance (CORDS).

Continue reading “Dr Ann Marie Kimball, MD — Physician, Epidemiologist, Rotarian — Global Public Service, Saving Lives” »